As a result of their specific nature, they are safe and well-tolerated
Talk to a doctor about what vitamin doses are right for you
As reports show, with the expiry of Novo Nordisks semaglutide exclusivity on January 4, 2026, Canada has emerged as the first major Western market where generic semaglutide can be legally produced and sold, subject to Health Canada approval
Efficacy and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in overweight/obese patients with or without diabetes mellitus: a systematic review and network meta-analysis
Individuals with a BMI over 25 and metabolic symptoms, or a BMI over 30, may be considered following a medical evaluation
Seek medical advice if you experience: New or worsening vision problems Severe or progressive weakness Loss of coordination or balance Confusion or cognitive changes Seizures These symptoms could indicate underlying conditions requiring investigation